Prognostic factors and pattern of long-term recovery with MLC601 (NeuroAiD™) in the Chinese medicine NeuroAiD efficacy on stroke recovery - Extension study

• Main Authors: Venketasubramanian, N, Lee, C.F, Young, S.H, Tay, S.S, Umapathi, T, Lao, A.Y, Gan, H.H, Baroque, A.C, Navarro, J.C, Chang, H.M, Advincula, J.M, Muengtaweepongsa, S, Chan, B.P.L, Chua, C.L, Wijekoon, N, De Silva, H.A, Hiyadan, J.H.B, Suwanwela, N.C, Wong, K.S.L, Poungvarin, N, Eow, G.B, Chen, C.L.H
• Other Authors: PHARMACOLOGY
• Format: Article
• Published: S. Karger AG 2020
• Subjects: mlc601; neuroprotective agent; unclassified drug; herbaceous agent; Neuroaid; adult; Article; brain ischemia; cerebrovascular accident; Chinese medicine; controlled study; female; follow up; human; major clinical study; male; middle aged; multicenter study (topic); National Institutes of Health Stroke Scale; priority journal; prognosis; randomized controlled trial (topic); Rankin scale; stroke rehabilitation; time to treatment; aged; Asia; clinical trial; convalescence; disability; double blind procedure; multicenter study; odds ratio; pathophysiology; procedures; psychology; randomized controlled trial; risk factor; time factor; treatment outcome; Aged; Disability Evaluation; Double-Blind Method; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Odds Ratio; Recovery of Function; Risk Factors; Stroke; Stroke Rehabilitation; Time Factors; Treatment Outcome
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/179244
• Institution: National University of Singapore

10.1159/000452285